Advance Search
HUANG Jie. Insulin glargine combined with oral hypoglycemic agents versus premixed insulin combined with oral hypoglycemic agents in treating patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2019, (20): 35-38. DOI: 10.7619/jcmp.201920010
Citation: HUANG Jie. Insulin glargine combined with oral hypoglycemic agents versus premixed insulin combined with oral hypoglycemic agents in treating patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2019, (20): 35-38. DOI: 10.7619/jcmp.201920010
shu

Insulin glargine combined with oral hypoglycemic agents versus premixed insulin combined with oral hypoglycemic agents in treating patients with type 2 diabetes mellitus

  • Department of Pharmacy, Yingtan People′s Hospital, Yingtan, Jiangxi, 335000

More Information
  • Received Date: August 16, 2019
  • Accepted Date: September 20, 2019
  • Available Online: February 28, 2021
  • Published Date: October 27, 2019
    Graphical Abstract
    • Abstract
  •   Objective  To compare the effect of insulin glargine combined with oral hypoglycemic agents and premixed insulin combined with oral hypoglycemic agents in treating patients with type 2 diabetes mellitus (T2DM).
      Methods  A total of 84 patients with T2DM were randomly divided into group A and group B, with 42 cases in each group. Group A was treated with subcutaneous injection of insulin glargine combined with acarbose, while group B was treated with premixed insulin combined with acarboses. The value of blood glucose monitoring, insulin dosage and blood sugar achievement were compared before and after treatment between two groups.
      Results  After treatment, the levels of fasting blood glucose (FBG), postprandial blood glucose (PBG) and glycosylated hemoglobin (HbA1c) in both groups were significantly lower than those before treatment (P < 0.05). There were no significant differences in the control rate of FBG, PBG and HbA1c between the two groups after treatment (P>0.05). The dosage of insulin in group A was significantly less than that in group B, and the incidence rate of hypoglycemia was significantly lower than that in group B (P < 0.05). There was no significant difference in the incidence rates of cardiovascular and cerebrovascular events between the two groups (P>0.05).
      Conclusion  Both insulin glargine and premixed insulin combined with acarbose can effectively control blood sugar, but insulin glargine combined with acarbose can significantly reduce insulin dosage and the incidence rate of hypoglycemia.
    • FullText(HTML)
    • References (17)
  • [1]
    荣义华, 谷巍, 耿建林, 等. 不同胰岛素皮下注射方案T2DM患者的血糖变异性比较[J]. 中国现代医学杂志, 2017, 27(17): 103-107. doi: 10.3969/j.issn.1005-8982.2017.17.022
    [2]
    Melladogil J M, Fuentemartín E, Lorenzo P I, et al. The type 2 diabetes-associated HMG20A gene is mandatory for islet beta cell functional maturity[J]. Cell Death & Disease, 2018, 9(3): 279-284. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833347/
    [3]
    许洪梅, 穆纯, 包頔, 等. 2型糖尿病患者低血糖恐惧行为现状及影响因素分析[J]. 中华糖尿病杂志, 2018, 10(11): 735-739. doi: 10.3760/cma.j.issn.1674-5809.2018.11.009
    [4]
    苏杭, 周健, 贾伟平. 2016年ADA糖尿病医学诊疗标准解读[J]. 中国医学前沿杂志, 2018, 10(1): 66-74. https://www.cnki.com.cn/Article/CJFDTOTAL-YXQY201601007.htm
    [5]
    世界卫生组织. 《全球糖尿病报告》[J]. 中国卫生政策研究, 2016, 15(4): 61-63. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWZ201604013.htm
    [6]
    颜穗珺, 李会芳. 中国糖尿病的患病概况[J]. 昆明医科大学学报, 2017, 38(3): 1-5. doi: 10.3969/j.issn.1003-4706.2017.03.001
    [7]
    Kumar S, Jang H C, Demira N G, et al. Efficacy and safety of once-daily insulin degludec/insulin aspart compared with once-daily insulin glargine in participants with Type 2 diabetes: a randomized, treat-to-target study[J]. Diabetic Medicine, 2017, 34(2): 180-188. doi: 10.1111/dme.13125
    [8]
    Pettus J, Roussel R, Zhou F L, et al. Rates of Hypoglycemia Predicted in Patients with Type 2 Diabetes on Insulin Glargine 300 U/ml Versus First-and Second-Generation Basal Insulin Analogs: The Real-World LIGHTNING Study[J]. Diabetes Therapy, 2019, 10(2): 617-633. doi: 10.1007/s13300-019-0568-8
    [9]
    谢静, 蒲丹岚, 杨刚毅, 等. 长效胰升血糖素样肽1类似物与甘精胰岛素治疗2型糖尿病患者疗效及安全性的Meta分析[J]. 中国糖尿病杂志, 2018, 26(2): 89-95. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGTL201802001.htm
    [10]
    Harreiter J, Kosi-Trebotic L, Lukas A, et al. Switch to Combined GLP1 Receptor Agonist Lixisenatide with Basal Insulin Glargine in Poorly Controlled T2DM Patients with Premixed Insulin Therapy: A Clinical Observation and Pilot Study in Nine Patients[J]. Diabetes Therapy, 2017, 8(3): 683-692. doi: 10.1007/s13300-017-0249-4
    [11]
    王曹锋, 蔡文玮, 陈谊, 等. 阿卡波糖控制不佳的老年2型糖尿病患者联合甘精胰岛素或中效胰岛素对血糖的影响[J]. 老年医学与保健, 2017, 23(2): 105-108. https://www.cnki.com.cn/Article/CJFDTOTAL-LYBJ201702014.htm
    [12]
    简树财, 刘毅, 李明秀, 等. 甘精胰岛素与预混胰岛素联合阿卡波糖治疗2型糖尿病的疗效及安全性评价[J]. 检验医学与临床, 2017, 14(11): 1605-1607. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGTL201405017.htm
    [13]
    魏冬红. 甘精胰岛素联合阿卡波糖治疗老年2型糖尿病疗效观察[J]. 现代中西医结合杂志, 2015, 24(20): 2221-2223. https://www.cnki.com.cn/Article/CJFDTOTAL-JXYY201502024.htm
    [14]
    王永芬. 甘精胰岛素联合阿卡波糖治疗老年糖尿病临床研究[J]. 中国药物与临床, 2019, 19(1): 53-54. https://www.cnki.com.cn/Article/CJFDTOTAL-YWLC201901024.htm
    [15]
    杨松, 谷媛媛, 李兆亮, 等. 沙格列汀或格列美脲联合甘精胰岛素对2型糖尿病患者血糖波动影响的观察[J]. 中国糖尿病杂志, 2015, 23(3): 237-240. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGTL201503015.htm
    [16]
    杨华, 许学忠, 祁平, 等. 甘精胰岛素注射液联合阿卡波糖片治疗继发性磺脲类药物失效的2型糖尿病的临床研究[J]. 中国临床药理学杂志, 2017, 33(3): 219-221. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ201703008.htm
    [17]
    芦荣, 苏文博, 刘芳. 皮下注射甘精胰岛素对2型糖尿病并发上消化道出血患者急性期血糖控制的效果分析[J]. 现代消化及介入诊疗, 2018, 23(1): 42-44. https://www.cnki.com.cn/Article/CJFDTOTAL-XDXH201801013.htm
    • Related Articles

  • Cited by

    Periodical cited type(3)

    1. 官俊杰，邓淑芳. 快速康复外科护理在达芬奇机器人辅助腹腔镜下肾上腺嗜铬细胞瘤切除术患者围手术期的应用. 中国医药指南. 2024(35): 102-104 .
    2. 吴沈雅，戴韻. 达芬奇机器人辅助下腹腔镜肾部分切除术后出血的观察与护理. 加速康复外科杂志. 2022(04): 184-187 .
    3. 周国永，刘伟波，张翠禄，杨有甜. 应用带纤毛弹簧圈栓塞治疗肾出血的临床疗效分析. 影像研究与医学应用. 2021(24): 38-41 .

    Other cited types(1)

Catalog

    Get Citation
    PDF
    XML
    Article views (321) PDF downloads (4) Cited by(4)
    Turn off MathJax
    Article Contents
    Abstract
    References

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return